Complete atrioventricular block as a clinical manifestation of cardiac sarcoidosis
M. V. Serova,
M. G. Poltavskaya,
Yu. Yu. Garmash,
D. A. Ivanova,
E. S. Pershina,
Yu. Zyuzya,
Yu. S. Sazonova,
M. Yu. Lukin,
I. V. Samoilenko,
M. A. Uyanaeva,
A. L. Syrkin,
G. G. Melkonyan https://doi.org/10.15829/1560-4071-2019-11-63-68
Abstract
Cardiac involvement in sarcoidosis is considered quite rare, but it can cause the first significant disease manifestations and patient’s death. Timely disease detection improves the effectiveness of treatment and prognosis. The article presents modern approaches to the diagnosis and management of patients with cardiac sarcoidosisusing clinical case of a patient hospitalized by ambulance with a first revealed symptomatic third-degree atrioventricular block. We described methods of examining this patient, as well as difficulties in differential diagnosis.
About the Authors
M. V. Serova
City Clinical Hospital № 4; I.M. Sechenov First Moscow State Medical University
Russian Federation
Russian Federation
Moscow.
M. G. Poltavskaya
I.M. Sechenov First Moscow State Medical University
Russian Federation
Competing Interests: конфликт интересов не заявляется
Russian Federation
Moscow.
Competing Interests: конфликт интересов не заявляется
Yu. Yu. Garmash
Moscow City Scientific and Practical Center control for Tuberculosis
Russian Federation
Competing Interests: конфликт интересов не заявляется
Russian Federation
Moscow.
Competing Interests: конфликт интересов не заявляется
D. A. Ivanova
Moscow City Scientific and Practical Center control for Tuberculosis
Russian Federation
Competing Interests: Конфликт интересов не заявляется
Russian Federation
Moscow.
Competing Interests: Конфликт интересов не заявляется
E. S. Pershina
Pirogov City Clinical Hospital № 1
Russian Federation
Competing Interests: конфликт интересов не завяляется
Russian Federation
Moscow.
Competing Interests: конфликт интересов не завяляется
Yu. Zyuzya
Research Institute of Human Morphology
Russian Federation
Competing Interests: конфликт инетересов не завяляется
Russian Federation
Moscow.
Competing Interests: конфликт инетересов не завяляется
Yu. S. Sazonova
City Clinical Hospital № 4
Russian Federation
Competing Interests: конфликт интересов не заявляется
Russian Federation
Moscow.
Competing Interests: конфликт интересов не заявляется
M. Yu. Lukin
City Clinical Hospital № 4
Russian Federation
Competing Interests: конфликт интересов не завяляется
Russian Federation
Moscow.
Competing Interests: конфликт интересов не завяляется
I. V. Samoilenko
City Clinical Hospital № 4; I.M. Sechenov First Moscow State Medical University
Russian Federation
Competing Interests: конфликт интересов не заявляется
Russian Federation
Moscow.
Competing Interests: конфликт интересов не заявляется
M. A. Uyanaeva
City Clinical Hospital № 4
Russian Federation
Competing Interests: конфликт интересов не заявляется
Russian Federation
Moscow.
Competing Interests: конфликт интересов не заявляется
A. L. Syrkin
I.M. Sechenov First Moscow State Medical University
Russian Federation
Competing Interests: конфликт интересов не заявляется
Russian Federation
Moscow.
Competing Interests: конфликт интересов не заявляется
G. G. Melkonyan
City Clinical Hospital № 4
Russian Federation
Competing Interests: конфликт интересов не заявляется
Russian Federation
Moscow.
Competing Interests: конфликт интересов не заявляется
References
1. Chuchalin AG, Vizel AA, Ilkovich MM, et al. Diagnosis and treatment of sarcoidosis. Summary of federal conciliative clinical recommendations, part I. Classification, etiopathogenesis, clinic. The Bulletin of Contemporary Clinical Medicine. 2014;7(4):62-70. (In Russ.) doi:10.20969/VSKM.2014.7(4).1-82.
2. Swigris JJ, Olson AL, Huie TJ, et al. Sarcoidosis-related mortality in the United States from 1988 to 2007. Am J Respir Crit Care Med. 2011;183:1524-30. doi:10.1164/rccm.201010-1679OC.
3. Birnie DH, Sauer WH, Bogun F, et al. HRS Expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm. 2014;11:1305-23. doi:10.1016/j.hrthm.2014.03.043.
4. Kandolin R, Lehtonen J, Kupari M. Cardiac sarcoidosis and giant cell myocarditis as causes of atrioventricular block in young and middle-aged adults. Circ Arrhythm Electrophysiol. 2011;4:303-9. doi:10.1161/CIRCEP.110.959254.
5. Nery PB, Beanlands RS, Nair G, et al. Middle aged patients with new onset atrioventricular block should be investigated for cardiac sarcoidosis. Heart Rhythm. 2013;10:S447. doi:10.1111/jce.12401.
6. Greulich S, Deluigi CC, Gloekler S, et al. CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis. JACC Cardiovasc Imaging. 2013;6:501-11. doi:10.1016/j.jcmg.2012.10.021.
7. Slart R, Glaudemans A, Lancelotti P, et al. A joint procedural position statement on imaging in cardiac sarcoidosis: from the Cardiovascular and Inflammation & Infection Committees of the European Association of Nuclear Medicine, the European Association of Cardiovascular Imaging, and the American Society of Nuclear Cardiology. Euro Heart J Cardiovasc Imaging. 2017;18:1073-89. doi:10.1093/ehjci/jex146.
8. Sadek MM, Yung D, Birnie DH, et al. Corticosteroid therapy for cardiac sarcoidosis: systematic review. Can J Cardiol. 2013;29:1034-41. doi:10.1016/j.cjca.2013.02.004.
9. Miyazaki S, Funabashi N, Nagai T, et al. Cardiac sarcoidosis complicated with atrioventricular block and wall thinning, edema and fibrosis in left ventricle: confirmed recovery to normal sinus rhythm and visualization of edema improvement by administration of predonisolone. Int J Cardiol. 2011;150:e4-e10. doi:10.1016/j.ijcard.2009.05.047.
10. Yodogawa K, Seino Y, Shiomura R, et al. Recovery of atrioventricular block following steroid therapy in patients with cardiac sarcoidosis. J Cardiol. 2013;62:320-5. doi:10.1016/j.jjcc.2013.07.007.
11. Yodogawa K, Seino Y, Ohara T, et al. Effect of corticosteroid therapy on ventricular arrhythmias in patients with cardiac sarcoidosis. Ann Noninvasive Electrocardiol. 2011;16:140-7. doi:10.5582/irdr.2015.01023.
12. Houston BA, Mukherjee M. Cardiac sarcoidosis: clinical manifestations, imaging characteristics, and therapeutic approach. Clinical Medicine Insights. Cardiology. 2014;8(Suppl 1):31-7. doi:10.4137/CMC.S15713.
13. Lynch JP, Hwang J, Bradfield J, et al. Cardiac involvement in sarcoidosis: evolving concepts in diagnosis and treatment. Semin Respir Crit Care Med. 2014;35(3):372-90. doi:10.1055/s-0034-1376889.
14. Moiseeva OM, Mikhailov EN, Mitrofanova LB, et al. Isolated sarcoidosis of the heart. Clinical case and literature review. Russian Journal of Cardiology. 2016;(1):99-104. (In Russ.) doi:10.15829/1560-4071-2016-1-99-104.
15. Kim JS, Judson MA, Donnino R, et al. Cardiac sarcoidosis. Am Heart J. 2009;157(1):9-21. doi:10.1016/j.ahj.2008.09.009.
Review
For citations:
Serova M.V., Poltavskaya M.G., Garmash Yu.Yu., Ivanova D.A., Pershina E.S., Zyuzya Yu., Sazonova Yu.S., Lukin M.Yu., Samoilenko I.V., Uyanaeva M.A., Syrkin A.L., Melkonyan G.G. Complete atrioventricular block as a clinical manifestation of cardiac sarcoidosis. Russian Journal of Cardiology. 2019;(11):63-68. (In Russ.) https://doi.org/10.15829/1560-4071-2019-11-63-68
Views:
763
Email this article 